Citations

Clear

4610 citation(s) found for "Lu, Brian".

Neuromyelitis optica spectrum disorder diagnostic criteria: Sensitivity and specificity are both important
Wingerchuk, Dean M. , Weinshenker, Brian G. , Weinshenker, Brian G

Mayo Clinic

Multiple Sclerosis Journal | January 12, 2017 | Volume: 23 | Issue: 2 | Pages: 182-184

10.1177/1352458516688352 | PMID 28080211 Get It

Wrist Instability
Carlsen, Brian T. , Shin, Alexander Y.

Mayo Clinic

Scandinavian Journal of Surgery | January 11, 2017 | Volume: 97 | Issue: 4 | Pages: 324-332

10.1177/145749690809700409 | PMID 19211387 Get It

The topic of wrist or carpal instability has been a source of confusion and miscommunication for decades. The terminology can often be difficult to understand and one surgeon's concept of instability may be completely different from another's. This is by no means a comprehensive review of carpal instability, which has often been the focus of numerous multi-volume textbooks. The purpose of this paper is to detail the basics of carpal instability, the anatomy, pathomechanics, terminology and basic principles of treatment.
IKBKE Is Required during KRAS-Induced Pancreatic Tumorigenesis
Rajurkar, Mihir, Dang, Kyvan , Fernández‐Barrena, Maite G. , Liu, Xiangfan, Fernández-Zapico, Martín E. , Lewis, Brian C., Mao, Junhao

Mayo Clinic

Cancer Research | January 9, 2017 | Volume: 77 | Issue: 2 | Pages: 320-329

10.1158/0008-5472.can-15-1684 | PMID 28069799 Get It

Abstract Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest malignancies lacking effective therapeutic strategies. Here, we show that the noncanonical IκB-related kinase, IKBKE, is a critical oncogenic effector during KRAS-induced pancreatic transformation. Loss of IKBKE inhibits the initiation and progression of pancreatic tumors in mice carrying pancreatic-specific KRAS activation. Mechanistically, we demonstrate that this protumoral effect of IKBKE involves the activation of GLI1 and AKT signaling and is independent of the levels of activity of the NF-κB pathway. Further analysis reveals that IKBKE regulates GLI1 nuclear translocation and promotes the reactivation of AKT post-inhibition of mTOR in PDAC cells. Interestingly, combined inhibition of IKBKE and mTOR synergistically blocks pancreatic tumor growth. Together, our findings highlight the functional importance of IKBKE in pancreatic cancer, support the evaluation of IKBKE as a therapeutic target in PDAC, and suggest IKBKE inhibition as a strategy to improve efficacy of mTOR inhibitors in the clinic. Cancer Res; 77(2); 320–9. ©2017 AACR.
Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient: 2016 update—executive summary
DeBlock, Heidi F., Erstad, Brian L. , Gray, Anthony, Jacobi, Judith , Jordan, Ché J., McGee, William T. , McManus, Claire, Meade, Maureen O. , Nix, Sean , Sands, Karen, Pino, Richard M. , Tescher, Ann, Arbour, Richard, Murray, Catherine Friederich, Mehta, Sangeeta , Tescher, Ann N, Murray, Michael J. , Patterson, Andrew J. , Rochwerg, Bram

Mayo Clinic

American Journal of Health-System Pharmacy | January 9, 2017 | Volume: 74 | Issue: 2 | Pages: 76-78

10.2146/ajhp160803 | PMID 28069681 Get It

Assessing mNIS+7Ionis and international neurologists' proficiency in a familial amyloidotic polyneuropathy trial
Dyck, Peter J., Dyck, Peter J., Kincaid, John C., Dyck, P. James B. , Chaudhry, Vinay , Goyal, Namita , Alves, Christina , Salhi, Hayet, Wiesman, Janice F. , Labeyrie, Céline , Robinson‐Papp, Jessica , Cardoso, Márcio , Laurá, Matilde , Ruzhansky, Katherine , Cortese, Andrea , Brannagan, Thomas H., Khoury, Julie, Khella, Sami, Ferreira, João , Wang, Annabel K., Pinto, Marcus Vinícius , Ayache, Samar S. , Benson, Merrill D., Coelho, Teresa , Polydefkis, Michael , Gorevic, Peter D., Planté‐Bordeneuve, Violaine , Whelan, Carol , Merlini, Giampaolo , Drachman, Brian, Conceição, Isabel , Klein, Christopher J. , Ackermann, Elizabeth J., Hughes, Steven G. , Mauermann, Michelle L. , Bergemann, R , Lodermeier, Karen A., Davies, Jenny L., Carter, Rickey E. , Litchy, William J. , Dyck, Peter J., Dyck, Peter J., Waddington‐Cruz, Márcia , Berk, John L. , Adams, David , Heitner, Stephen B. , Gertz, Morie A. , Merlini, Giampaolo , Pinto, Marcus V , Klein, Christopher J , Brannagan, T H , Carter, Rickey E , Conceição, Isabel , Mauermann, Michelle L

Mayo Clinic

Muscle & Nerve | January 7, 2017 | Volume: 56 | Issue: 5 | Pages: 901-911

10.1002/mus.25563 | PMID 28063170 Get It

ABSTRACTIntroductionPolyneuropathy signs (Neuropathy Impairment Score, NIS), neurophysiologic tests (m+7Ionis), disability, and health scores were assessed in baseline evaluations of 100 patients entered into an oligonucleotide familial amyloidotic polyneuropathy (FAP) trial.MethodsWe assessed: (1) Proficiency of grading neurologic signs and correlation with neurophysiologic tests, and (2) clinometric performance of modified NIS+7 neurophysiologic tests (mNIS+7Ionis) and its subscores and correlation with disability and health scores.ResultsThe mNIS+7Ionis sensitively detected, characterized, and broadly scaled diverse polyneuropathy impairments. Polyneuropathy signs (NIS and subscores) correlated with neurophysiology tests, disability, and health scores. Smart Somatotopic Quantitative Sensation Testing of heat as pain 5 provided a needed measure of small fiber involvement not adequately assessed by other tests.ConclusionsSpecially trained neurologists accurately assessed neuropathy signs as compared to referenced neurophysiologic tests. The score, mNIS+7Ionis, broadly detected, characterized, and scaled polyneuropathy abnormality in FAP, which correlated with disability and health scores. Muscle Nerve 56: 901–911, 2017
ACR Appropriateness Criteria® Locally Advanced, High-Risk Prostate Cancer
McLaughlin, Patrick W. , Liss, Adam L., Nguyen, Paul L. , Assimos, Dean G. , D’Amico, Anthony V. , Gustafson, Gary, Keole, Sameer R., Liauw, Stanley L. , Movsas, Benjamin , Prestidge, Bradley R., Showalter, Timothy N. , Taira, Al V., Vapiwala, Neha , GOTTSCHALK, ALEXANDER R. , Lloyd, Shane , Davis, Brian J. , Liauw, Stanley L

Mayo Clinic

American Journal of Clinical Oncology | January 6, 2017 | Volume: 40 | Issue: 1 | Pages: 1-10

10.1097/coc.0000000000000354 | PMID 28059930 Get It

Purpose: To present the most updated American College of Radiology consensus guidelines formed from an expert panel on treatment of locally advanced, high-risk prostate cancer Methods: The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer-reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment. Results: The panel summarized the most recent and relevant literature on the topic and voted on 4 clinical variants illustrating the appropriate management of locally advanced, high-risk cancer. Numerical rating and commentary reflecting the panel consensus was given for each treatment approach in each variant. Conclusions: Aggressive local approaches including surgery followed by adjuvant XRT, beam combined with androgen deprivation therapy, and beam combined with brachytherapy have resulted in unpresented success in locally advanced, high-risk prostate cancer. By combining most recent medical literature and expert opinion, this guideline can aid clinicians in the appropriate integration of available therapeutic modalities.
The Effect of Metacarpophalangeal Joint Hyperextension on Outcomes in the Surgical Treatment of Carpometacarpal Joint Arthritis
Hogezand, Rose van, Babovic, Nikola, Carlsen, Brian T. , van Hogezand, Rose M, Carlsen, Brian, Brogan, David M. , Hogezand, Rose M. Van, Kakar, Sanjeev

Mayo Clinic

Journal of Wrist Surgery | December 28, 2016 | Volume: 06 | Issue: 03 | Pages: 188-193

10.1055/s-0036-1597836 | PMID 28725499 Get It

Purpose In the surgical treatment of thumb carpometacarpal (CMC) joint arthritis, the effect of mild preoperative metacarpophalangeal (MCP) hyperextension on postoperative functional outcomes is unknown. We sought to examine outcomes after surgical treatment of CMC arthritis in patients with and without mild preexisting MCP deformity. Methods A retrospective review was conducted to analyze the functional outcomes of patients treated for CMC arthritis at a single institution from March 1998 to May 2009. All patients were treated with one of two standard CMC arthroplasty procedures—either ligament reconstruction tendon interposition (LRTI) or a Weilby procedure—and none had additional procedures to address MCP hyperextension. Pre- and postoperative assessments included pinch and grip strength, degree of MCP hyperextension, and thumb radial and palmar abduction. A t-test was used to assume unequal variances. Results A total of 203 patients were followed for an average of 27.3 months. Patients were divided into two groups: (1) patients without preoperative MCP hyperextension (167 patients) and (2) patients with mild but untreated preoperative MCP hyperextension (≤ 30 degrees; 36 patients). All patients underwent either a Weilby procedure (118 patients) or an LRTI; 85 patients). The main difference between techniques was the use of the abductor pollicis longus tendon as a post to secure the flexor carpi radialis (Weilby) or the use of a bone tunnel in the first metacarpal (LRTI). Analysis of the preoperative data showed no difference in the baseline parameters among both the groups, with the exception of MCP hyperextension. Postoperatively, neither the type of CMC procedure nor the presence of MCP hyperextension demonstrated any significant differences in key pinch, tip pinch, grip strength, and radial or palmar abduction of the thumb between the groups. Conclusion There were no statistically significant differences in improvement of functional outcomes after surgery when comparing patients without preoperative MCP hyperextension to patients with untreated MCP hyperextension of less than 30 degrees. Level of Evidence Level III, retrospective comparative study.
Outcomes of surgically treated human papillomavirus–related oropharyngeal squamous cell carcinoma with N3 disease
Zenga, Joseph , Haughey, Bruce H. , Jackson, Ryan S. , Chrisinger, John S.A. , Bhatt, Neel K. , Martin, Eliot J., Moore, Eric J. , Paniello, Randal C., Rich, Jason T. , Adkins, Douglas R. , Gay, Hiram A. , Kallogjeri, Dorina , Thorstad, Wade , Nussenbaum, Brian A. , Chrisinger, John S A

Mayo Clinic

The Laryngoscope | December 24, 2016 | Volume: 127 | Issue: 9 | Pages: 2033-2037

10.1002/lary.26455 | PMID 28008626 Get It

Objectives/HypothesisTo evaluate outcomes for patients with pathological N3 (pN3) neck disease from human papillomavirus (HPV)–related oropharyngeal squamous cell carcinoma (OPSCC) and determine variables predictive of survival.Study DesignRetrospective case series with chart review.MethodsThis study was conducted between 1998 and 2013 and included patients with HPV‐related OPSCC treated with surgery with or without adjuvant therapy and who had pN3 nodal disease. The primary outcome was disease‐specific survival (DSS). Secondary outcomes included overall survival (OS), disease‐free survival (DFS), adverse events, and gastrostomy tube rates.ResultsThirty‐nine patients were included, of whom 36 (90%) underwent adjuvant therapy. Median follow‐up was 39 months (range, 2–147 months). Mean age was 56 years, and 87% were male. Seventeen patients (44%) underwent selective neck dissection, whereas six (15%) underwent radical (n = 2) or extended radical (n = 4) neck dissection. Ninety‐two percent had extracapsular extension. Five‐year Kaplan‐Meier estimated DSS, OS, and DFS were 89% (95% confidence interval [CI]: 79%–99%), 87% (95% CI: 75%–99%), and 84% (95% CI: 72%–96%), respectively. The disease recurrence rate was 10% (5% regional, 5% distant metastasis). Patients with less than 5 pathologically positive lymph nodes (P = .041) had improved DFS.ConclusionsPatients with HPV‐related OPSCC and pN3 nodal disease treated with surgery and adjuvant therapy have very favorable long‐term survival and regional control. Patients with five or more pathologically positive lymph nodes may be at higher risk for recurrence.Level of Evidence4. Laryngoscope, 127:2033–2037, 2017
Improving Prediction of Postoperative Myocardial Infarction With High-Sensitivity Cardiac Troponin T and NT-proBNP
Kopec, Michael, Duma, Andreas , Helwani, Mohammad A. , Brown, Jamie , Brown, Frank, Gage, Brian F. , Gibson, David W., Novak, Eric, Jaffe, Allan S. , Apple, Fred S. , Scott, Mitchell G., Nägele, Peter , Miller, J. Philip , Jaffe, Allan S.

Mayo Clinic

Anesthesia & Analgesia | December 21, 2016 | Volume: 124 | Issue: 2 | Pages: 398-405

10.1213/ane.0000000000001736 | PMID 28002165 Get It

BACKGROUND: This study sought to determine whether preoperatively measured high-sensitivity cardiac troponin T (hs-cTnT) and N -terminal pro-brain natriuretic peptide (NT-proBNP) improve cardiac risk prediction in patients undergoing major noncardiac surgery compared with the standard risk indices. METHODS: In this ancillary study to the Vitamins in Nitrous Oxide trial, patients were included who had preoperative hs-cTnT and NT-proBNP measured (n = 572). Study outcome was the incidence of postoperative myocardial infarction (MI) within the first 3 postoperative days. hs-cTnT was considered elevated if >14 ng/L and NT-proBNP if >300 ng/L. Additional cutoff values were investigated on the basis of receiver operating characteristic statistics. Biomarker risk prediction was compared with Lee’s Revised Cardiac Risk Index (RCRI) with the use of standard methods and net reclassification index. RESULTS: The addition of hs-cTnT (>14 ng/L) and NT-proBNP (>300 ng/L) to RCRI significantly improved the prediction of postoperative MI (event rate 30/572 [5.2%], Area under the receiver operating characteristic curve increased from 0.590 to 0.716 with a 0.66 net reclassification index [95% confidence interval 0.32–0.99], P < .001). The use of 108 ng/L as a cutoff for NT-proBNP improved sensitivity compared with 300 ng/L (0.87 vs 0.53). Sensitivity, specificity, positive, and negative predictive value for hs-cTnT were 0.70, 0.60, 0.09, and 0.97 and for NT-proBNP were 0.53, 0.68, 0.08, and 0.96. CONCLUSIONS: The addition of cardiac biomarkers hs-cTnT and NT-proBNP to RCRI improves the prediction of adverse cardiac events in the immediate postoperative period after major noncardiac surgery. The high negative predictive value of preoperative hs-cTnT and NT-proBNP suggest usefulness as a “rule-out” test to confirm low risk of postoperative MI.
Phenotypic and functional characterization of a bortezomib-resistant multiple myeloma cell line by flow and mass cytometry
Sachs, Zohar , Noble-Orcutt, Klara E. , Mitra, Amit , Ness, Brian G. Van , Linden, Michael A. , Baughn, Linda B. , Sachs, Zohar

Mayo Clinic

Leukemia & Lymphoma | December 19, 2016 | Volume: 58 | Issue: 8 | Pages: 1931-1940

10.1080/10428194.2016.1266621 | PMID 27981867 Get It